Items tagged with Drug-resistant TB
Parasite sequencing provides mutation set to predict tuberculosis treatment success (post)
A retrospective study published online today in Lancet Infectious Diseases suggests mutation patterns found by sequencing many Mycobacterium tuberculosis isolates can provide a framework for predicting drug resistance or susceptibility.
Multidrug-resistant TB appears less transmissible in households than drug-susceptible TB (post)
Some strains of multidrug resistant tuberculosis (MDRTB) may have a lower fitness (be less capable of spreading) than drug-susceptible tuberculosis bacteria, according to a study published this week in PLOS Medicine. The study, conducted by Louis Grandjean of Imperial College London, and colleagues, compared new tuberculosis cases among household contacts of tuberculosis patients in South Lima and Callao, Peru to determine the relative fitness of MDRTB versus drug-susceptible tuberculosis.
STREAM clinical trial reaches recruitment target (post)
24 June 2015 - The STREAM clinical trial has enrolled its 400th patient, meeting the recruitment target for Stage 1 of the comparison of a shorter 9-month treatment regimen for multidrug-resistant tuberculosis (MDR-TB) with the World Health Organization-approved treatment regimen.
DR-TB Scale-up Treatment Action Team (STAT) (post)
25 June 2015 - In March 2015, Médecins Sans Frontières (MSF), ACTION Global Health Advocacy Partnership, SWIFT Response Project, Treatment Action Campaign (TAC), Treatment Action Group (TAG) and 84 other organisations issued a call to action urging global health actors and the TB community to form a consortium with the objective of meeting time-bound, concrete targets for scaling up use of new drugs in DR-TB treatment.
Expert panel: Anti-TB drugs and arrhythmia: Theoretical concern or real risk? (post)
When: July 6, 2015 - July 10, 2015
Where: Virtual, online panel at GHDonline.org
Risk factors for acquisition of drug resistance during multidrug-resistant tuberculosis treatment, Arkhangelsk Oblast, Russia, 2005–2010 (post)
Abstract
Supercharged tuberculosis, made in India (post)
A patient with extensively drug-resistant TB flew from Mumbai to Chicago, and the deadly disease could become an infamous export due to problems in India's public health system
India: Nudge to tweak TB treatment rules (post)
New Delhi, July 6: India could prevent on average 18,000 people from developing multi-drug-resistant tuberculosis every year over the next decade if the health ministry accelerates proposed changes in TB diagnosis and treatment policies, public health experts have said.
India: TB drug resistance weaker than feared, survey suggests (post)
Initial indications from the the first-ever tuberculosis drug resistance survey commissioned by the Ministry of Health show that around 2 per cent of new TB cases are resistant to some TB drugs while about 9 per cent of patients who have undergone TB treatment previously and have again been diagnosed with the disease are infected by the drug-resistant variety.
Linezolid for XDR-TB — final study outcomes (post)
We previously reported 4-month culture conversion rates among patients with chronic extensively drug-resistant tuberculosis (XDR-TB) who received linezolid (1). By 4 months, 15 of 19 patients (79%) in the immediate-start group and 7 of 20 (35%) in the delayed-start group had conversion to a negative sputum culture (P=0.001). After 6 months of linezolid treatment, 34 of 39 patients (87%) had negative sputum cultures. Here, we report final study outcomes for these patients 1 year after the end of treatment, 36 months after they began the study.
Page 17 of 117 · Total posts: 0
←First 16 17 18 Last→